Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
Download a publication order form here or subscribe here.
Latest Headlines
Ill. Judge Strikes Testimony of J&J Exec During Talcum Powder Ovarian Cancer Trial
Talcum Powder MDL Judge Targets April 2022 as Date for First Trial in Coordinated Docket
Plaintiffs in Ill. Talcum Powder Ovarian Cancer Trial Could Rest as Early as Friday
Plaintiffs in Baby Powder Trial Against J&J Oppose Defendant’s Motion for Mistrial
N.J. State Court Outlines Process for Selecting Bellwether Cases for Trial in Talcum Powder Docket
PTI Union Asks Federal Court to Stay Time in Which Company Has To Respond to Recently Refiled Suits
RECENT COMMENTARY
Talc Verdict Overturned as Appellate Court Finds Experts’ Opinions Lacking